Literature DB >> 33596906

Systematic review of pragmatic randomised control trials assessing the effectiveness of professional pharmacy services in community pharmacies.

R Varas-Doval1, L Saéz-Benito2,3, M A Gastelurrutia3, S I Benrimoj3, V Garcia-Cardenas3,4, F Martinez-Martínez3.   

Abstract

BACKGROUND: Implementation of Professional Pharmacy Services (PPSs) requires a demonstration of the service's impact (efficacy) and its effectiveness. Several systematic reviews and randomised controlled trials (RCT) have shown the efficacy of PPSs in patient's outcomes in community pharmacy. There is, however, a need to determine the level of evidence on the effectiveness of PPSs in daily practice by means of pragmatic trials. To identify and analyse pragmatic RCTs that measure the effectiveness of PPSs in clinical, economic and humanistic outcomes in the community pharmacy setting.
METHODS: A systematic search was undertaken in MEDLINE, EMBASE, the Cochrane Library and SCIELO. The search was performed on January 31, 2020. Papers were assessed against the following inclusion criteria (1) The intervention could be defined as a PPS; (2) Undertaken in a community pharmacy setting; (3) Was an original paper; (4) Reported quantitative measures of at least one health outcome indicator (ECHO model); (5) The design was considered as a pragmatic RCT, that is, it fulfilled 3 predefined attributes. External validity was analyzed with PRECIS- 2 tool.
RESULTS: The search strategy retrieved 1,587 papers. A total of 12 pragmatic RCTs assessing 5 different types of PPSs were included. Nine out of the 12 papers showed positive statistically significant differences in one or more of the primary outcomes (clinical, economic or humanistic) that could be associated with the following PPS: Smoking cessation, Dispensing/Adherence service, Independent prescribing and MTM. No paper reported on cost-effectiveness outcomes.
CONCLUSIONS: There is limited available evidence on the effectiveness of community-based PPS. Pragmatic RCTs to evaluate clinical, humanistic and economic outcomes of PPS are needed.

Entities:  

Keywords:  Clinical pharmacy services; Community pharmacy; Community pharmacy services; Comparative effectiveness research; Naturalistic; Pharmaceutical care; Pragmatic clinical trials; Professional pharmacy services

Mesh:

Year:  2021        PMID: 33596906      PMCID: PMC7890900          DOI: 10.1186/s12913-021-06150-8

Source DB:  PubMed          Journal:  BMC Health Serv Res        ISSN: 1472-6963            Impact factor:   2.655


  75 in total

1.  Transitions, part 1: beyond pharmaceutical care.

Authors:  R W Holland; C M Nimmo
Journal:  Am J Health Syst Pharm       Date:  1999-09-01       Impact factor: 2.637

2.  Effectiveness of pharmacist counseling combined with nicotine replacement therapy: a pragmatic randomized trial with 6,987 smokers.

Authors:  Mary Jean Costello; Beth Sproule; J Charles Victor; Scott T Leatherdale; Laurie Zawertailo; Peter Selby
Journal:  Cancer Causes Control       Date:  2010-12-12       Impact factor: 2.506

3.  Medication therapy management: 10 years of experience in a large integrated health care system.

Authors:  Djenane Ramalho de Oliveira; Amanda R Brummel; David B Miller
Journal:  J Manag Care Pharm       Date:  2010-04

Review 4.  Does adding noradrenaline reuptake inhibition to selective serotonin reuptake inhibition improve efficacy in patients with depression? A systematic review of meta-analyses and large randomised pragmatic trials.

Authors:  Andrew J Bradley; Alan J Lenox-Smith
Journal:  J Psychopharmacol       Date:  2013-07-05       Impact factor: 4.153

5.  Randomized Trial of the Effect of Pharmacist Prescribing on Improving Blood Pressure in the Community: The Alberta Clinical Trial in Optimizing Hypertension (RxACTION).

Authors:  Ross T Tsuyuki; Sherilyn K D Houle; Theresa L Charrois; Michael R Kolber; Meagen M Rosenthal; Richard Lewanczuk; Norm R C Campbell; Dale Cooney; Finlay A McAlister
Journal:  Circulation       Date:  2015-06-10       Impact factor: 29.690

6.  The need for more evidence-based studies to justify the economic value for the provision of medication therapy management and other clinical pharmacy services.

Authors:  Abiola O Oladapo; Jamie C Barner; Karen L Rascati
Journal:  Clin Ther       Date:  2012-11       Impact factor: 3.393

Review 7.  Impact of telephonic comprehensive medication reviews on patient outcomes.

Authors:  Evan A DeZeeuw; Ashley M Coleman; Milap C Nahata
Journal:  Am J Manag Care       Date:  2018-02-01       Impact factor: 2.229

8.  A randomized, controlled pragmatic trial of telephonic medication therapy management to reduce hospitalization in home health patients.

Authors:  Alan J Zillich; Margie E Snyder; Caitlin K Frail; Julie L Lewis; Donny Deshotels; Patrick Dunham; Heather A Jaynes; Jason M Sutherland
Journal:  Health Serv Res       Date:  2014-04-09       Impact factor: 3.402

9.  Supporting adherence for people starting a new medication for a long-term condition through community pharmacies: a pragmatic randomised controlled trial of the New Medicine Service.

Authors:  Rachel Ann Elliott; Matthew J Boyd; Nde-Eshimuni Salema; James Davies; Nicholas Barber; Rajnikant Laxmishanker Mehta; Lukasz Tanajewski; Justin Waring; Asam Latif; Georgios Gkountouras; A J Avery; Antony Chuter; Christopher Craig
Journal:  BMJ Qual Saf       Date:  2015-12-08       Impact factor: 7.035

Review 10.  Making trials matter: pragmatic and explanatory trials and the problem of applicability.

Authors:  Shaun Treweek; Merrick Zwarenstein
Journal:  Trials       Date:  2009-06-03       Impact factor: 2.279

View more
  1 in total

Review 1.  A review of pragmatic trials found a high degree of diversity in design and scope, deficiencies in reporting and trial registry data, and poor indexing.

Authors:  Stuart G Nicholls; Kelly Carroll; Spencer Phillips Hey; Merrick Zwarenstein; Jennifer Zhe Zhang; Hayden P Nix; Jamie C Brehaut; Joanne E McKenzie; Steve McDonald; Charles Weijer; Dean A Fergusson; Monica Taljaard
Journal:  J Clin Epidemiol       Date:  2021-03-28       Impact factor: 6.437

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.